NCCN Panel Assesses Health Care Policy Winds in an Election Year: Payment Reform, Data Sharing, and Patient Access
The second roundtable discussion of the NCCN 21st Annual Conference had pundits from both sides of the aisle discuss the stakes in an election year for people with cancer Please note: This release includes expanded quotations, updating and clarifying a previous version issued by NCCN on April 7, 2016. FORT WASHINGTON, PA - The next President of the United States will face multiple challenges in managing the nation's health care and, in particular, cancer care - most notably how to pay ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 13, 2016 Category: Cancer & Oncology Source Type: news

NCCN 21st Annual Conference Convened Experts in Key Oncology Issues; New and Updated NCCN Guidelines Presented
More than 1,600 oncology professionals attended the NCCN 21st Annual Conference, which featured presentations of the latest developments in the treatment of more than 15 cancer types, as well as expert roundtables and panel discussions. FORT WASHINGTON, PA -The NCCN 21st Annual Conference: Advancing the Standard of Cancer Care™ was hosted by the National Comprehensive Cancer Network® (NCCN®) from March 31 - April 2, 2016, at The Diplomat in Hollywood, Florida. 'This year's conference was r... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 11, 2016 Category: Cancer & Oncology Source Type: news

For Breast Cancer, When to Screen or Not to Screen? That is the Question Plaguing the Minds of U.S. Women—and their Clinicians
Representatives from American Cancer Society, National Comprehensive Cancer Network (NCCN), and U.S. Preventive Services Task Force deliberated recent controversies in breast cancer screening recommendations. In 2015, American Cancer Society (ACS) caused quite a stir in the oncology community-and among women in general-with the updated recommendation that women of average risk for breast cancer should commence annual mammography at age 45. Previously, ACS recommended that mammography begin at... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 9, 2016 Category: Cancer & Oncology Source Type: news

NCCN Welcomes University of Wisconsin Carbone Cancer Center to Its Alliance of Leading Cancer Centers
University of Wisconsin Carbone Cancer Center has been named the newest NCCN Member Institution; NCCN now has 27 Member Institutions serving patients throughout the United States. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®), an alliance of the nation's leading cancer centers dedicated to quality, effectiveness, and efficiency of cancer care, today announced that University of Wisconsin Carbone Cancer Center has been elected to institutional membership. NCCN no... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 6, 2016 Category: Cancer & Oncology Source Type: news

NCCN Expert Panel Sets the Record Straight on Palliative Care and its Value in the Cancer Care Continuum
The NCCN 21st Annual Conference kicked off with a look into the world of palliative care, exploring barriers to patient access and means to establish multidisciplinary palliative care teams. The number of people being diagnosed with cancer in the United States is increasing year over year, reaching more than 1.6 million in 2015. As the cancer death rate also continues to rise, an increasing amount of attention has been focused on the unique challenges of patients, care teams, and caregivers f... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 5, 2016 Category: Cancer & Oncology Source Type: news

Timothy J. Eberlein, MD, Elected Chairman of the NCCN Board of Directors; New Officers Elected
Timothy J. Eberlein, MD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, has been elected Chairman of the NCCN Board of Directors, succeeding Samuel M. Silver, MD, PhD, University of Michigan Comprehensive Cancer Center. Timothy Eberlein, MD FORT WASHINGTON, PA - Timothy J. Eberlein, MD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, has been elected Chairman of th... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 4, 2016 Category: Cancer & Oncology Source Type: news

NCCN Foundation Awards Grants to Six Young Investigators
The NCCN Foundation has awarded its sixth series of Young Investigator Awards to six oncology researchers from NCCN Member Institutions; the awards provide grants of $150,000 over a two-year period for research initiatives focused on assessing and improving outcomes in cancer care. FORT WASHINGTON, PA - The NCCN Foundation® has awarded grants to six young investigators from NCCN Member Institutions. These awardees, who are dedicated to advancing and discovering new treatments for cancer, enh... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - April 1, 2016 Category: Cancer & Oncology Source Type: news

Beating Prostate Cancer: “We’re Taking off the Brakes” (City of Hope Comprehensive Cancer Center)
Researchers at City of Hope believe they are on the verge of significant headway in the treatment of advanced prostate cancer, thanks to new thinking and 'staggering' early success. City of Hope Comprehensive Cancer Center is one of the 26 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 30, 2016 Category: Cancer & Oncology Source Type: news

Stealth Mode: How Metastatic Cancer Cells Evade Detection by the Immune System (Memorial Sloan Kettering Cancer Center)
Even after successful treatment, cancer can sometimes come back years later and spread to different organs. This is called latent metastasis. A new study by MSK scientists sheds light on how cancer cells hide out and remain undetected by our immune system, opening up a promising new avenue for treatment. Memorial Sloan Kettering Cancer Center is one of the 26 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 24, 2016 Category: Cancer & Oncology Source Type: news

Cancer Center Awards First ‘Impact Grants’ for High-Risk, High-Reward Projects (UCSF Helen Diller Family Comprehensive Cancer Center)
Eleni Linos, MD, MPH, DrPH, and Stephen Francis, MS, PhD, have been awarded the first UCSF Cancer Center Impact Grants, to pursue high-risk, high-reward research projects that would've been unlikely to be funded through conventional mechanisms. The grants - each $250,000 - were announced following a highly competitive selection process and a live 'Shark Tank'-style pitch event last week. UCSF Helen Diller Family Comprehensive Cancer Center is one of the 26 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 23, 2016 Category: Cancer & Oncology Source Type: news

Interventions Required to Reduce Non-Cancer-Related Hospitalizations for Elderly Men after Prostate Cancer Diagnosis, Study Finds
A new study published in the February issue of JNCCN finds that men older than 67 who are diagnosed with prostate cancer are 37 percent more likely to have non-cancer-related hospitalization after diagnosis than before diagnosis, pointing to the need to better manage non-cancer conditions after a cancer diagnosis. FORT WASHINGTON, PA - A cancer diagnosis presents challenges in managing other existing non-cancer health conditions. In many cases, these chronic conditions may worsen until hospit... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 23, 2016 Category: Cancer & Oncology Source Type: news

New Treatment Reduces Precancerous Polyps in Hereditary Cancer Patients (Huntsman Cancer Institute at the University of Utah)
Inheriting a mutation in the APC gene leads to a nearly 100% lifetime risk of colorectal cancer. While colon cancer can be kept at bay by removing the large intestine, these patients also have up to a 15% risk of getting cancer in the small intestine, which is the leading cause of cancer death in this patient group. A new study published in the Journal of the American Medical Association (JAMA), has identified the first prevention treatment for these patients, a two-drug combination that signifi... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 22, 2016 Category: Cancer & Oncology Source Type: news

How Much Does Chemo Impact Fertility? (Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance)
A new Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance study looked at chemotherapy's impact on the fertility of young cancer patients later in life. Women fared better, for the most part, with about 70 percent of survivors able to have kids. Men were significantly less likely to father children after undergoing chemotherapy as kids. Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance is one of the 26 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 22, 2016 Category: Cancer & Oncology Source Type: news

Cancer Care in an Election Year, Palliative Care Challenges, Incorporating Patient Values, and Guidelines Updates Featured at NCCN Annual Conference
Approximately 1,700 oncology stakeholders are expected to attend NCCN's 21st Annual Conference: Advancing the Standard of Cancer Care™, March 31 - April 2, 2016, in Hollywood, Florida. FORT WASHINGTON, PA - The National Comprehensive Cancer Network® (NCCN®) will host its 21st Annual Conference: Advancing the Standard of Cancer Care™, March 31 - April 2, 2016, at The Diplomat in Hollywood, Florida. Approximately 1,700 physicians, nurses, pharmacists, and other oncology stakeholders and repr... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 19, 2016 Category: Cancer & Oncology Source Type: news

New MD Anderson-Developed Breast Cancer Staging System Emphasizes Importance of Tumor Biology as Prognostic Indicator (The University of Texas MD Anderson Cancer Center)
A new breast cancer staging system developed by researchers at The University of Texas MD Anderson Cancer Center finds that incorporating tumor biology is a critical prognostic indicator for women who undergo neoadjuvant, or pre-surgical, therapy for breast cancer. The University of Texas MD Anderson Cancer Center is one of the 26 NCCN Member Institutions. ... (Source: National Comprehensive Cancer Network)
Source: National Comprehensive Cancer Network - March 17, 2016 Category: Cancer & Oncology Source Type: news